figshare
Browse
13058_2016_691_MOESM3_ESM.pdf (72.49 kB)

Additional file 3: Table S2. of Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer

Download (72.49 kB)
journal contribution
posted on 2016-03-15, 05:00 authored by Ian Krop, Shanu Modi, Patricia LoRusso, Mark Pegram, Ellie Guardino, Betsy Althaus, Dan Lu, Alexander Strasak, Anthony Elias
All-grade AEs (occurring in ≥20 %) or grade ≥3 AEs (occurring in >3 %) of the total patient population in phase 1b. (PDF 72 kb)

Funding

Genentech, Inc.

History

Usage metrics

    Breast Cancer Research

    Categories

    Keywords

    AdditionalpertuzumabHER 2-positive metastatic breast cancer All-grade AEsPDF 72 kbPhase2.phase 1 btrastuzumab emtansinepaclitaxelT-DMpatient population

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC